• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

舒必利对产后泌乳不足的影响。

Effect of sulpiride on poor puerperal lactation.

作者信息

Aono T, Aki T, Koike K, Kurachi K

出版信息

Am J Obstet Gynecol. 1982 Aug 15;143(8):927-32. doi: 10.1016/0002-9378(82)90476-8.

DOI:10.1016/0002-9378(82)90476-8
PMID:7102768
Abstract

Forty-two primiparous and 54 multiparous women with total yields of milk not exceeding 50 ml for the first 3 postpartum days were treated with 100 mg of oral sulpiride or placebo for 4 days from the third postpartum day. In the primiparous mothers, the mean daily yield of milk in the sulpiride group increased significantly (p less than 0.01) over that in the control group after the fourth postpartum day. Mean (+/- SE) total volumes of milk for the third to fifth postpartum days were 661.5 +/- 64.4 and 441.2 +/- 51.2 ml in the sulpiride and the control groups, respectively. However, in the multiparous mothers, no significant difference between the control and the sulpiride group was noted in total yield of milk, since a good increase in the secretion of milk was obtained without medication in these mothers. Determinations of daily serum levels of prolactin in 20 primiparous women revealed significantly higher concentrations in the sulpiride group. The ratio of primiparous mothers with complete breast-feeding 1 month after delivery was higher in the sulpiride group (55%) than in the control group (30%), whereas there was no difference between the control group and the sulpiride group of multiparous women. These data indicate that poor initiation of puerperal lactation in primiparous mothers can be effectively treated with oral sulpiride.

摘要

42名初产妇和54名经产妇,产后头3天的总产奶量不超过50毫升,从产后第3天起,用100毫克口服舒必利或安慰剂治疗4天。在初产妇中,舒必利组产后第4天之后的日均产奶量比对照组显著增加(p小于0.01)。舒必利组和对照组产后第3至5天的平均(±标准误)总产奶量分别为661.5±64.4毫升和441.2±51.2毫升。然而,在经产妇中,舒必利组和对照组的总产奶量没有显著差异,因为这些经产妇在未用药的情况下产奶量也有良好增加。对20名初产妇每日血清催乳素水平的测定显示,舒必利组的浓度显著更高。舒必利组产后1个月完全母乳喂养的初产妇比例(55%)高于对照组(30%),而经产妇的对照组和舒必利组之间没有差异。这些数据表明,初产妇产后泌乳启动不佳可用口服舒必利有效治疗。

相似文献

1
Effect of sulpiride on poor puerperal lactation.舒必利对产后泌乳不足的影响。
Am J Obstet Gynecol. 1982 Aug 15;143(8):927-32. doi: 10.1016/0002-9378(82)90476-8.
2
Augmentation of puerperal lactation by oral administration of sulpiride.口服舒必利增加产后泌乳量。
J Clin Endocrinol Metab. 1979 Mar;48(3):478-82. doi: 10.1210/jcem-48-3-478.
3
Sulpiride isomers and milk secretion in puerperium.舒必利异构体与产褥期乳汁分泌
Clin Exp Obstet Gynecol. 1982;9(3):144-7.
4
Treatment of inadequate lactation with oral sulpiride and buccal oxytocin.口服舒必利和颊含催产素治疗泌乳不足
Obstet Gynecol. 1984 Jan;63(1):57-60.
5
Sulpiride improves inadequate lactation.舒必利可改善泌乳不足。
Br Med J (Clin Res Ed). 1982 Jul 24;285(6337):249-51. doi: 10.1136/bmj.285.6337.249.
6
[Hormonal control of lactation].[泌乳的激素调控]
Nihon Sanka Fujinka Gakkai Zasshi. 1990 Aug;42(8):867-72.
7
Early lactation performance in primiparous and multiparous women in relation to different maternity home practices. A randomised trial in St. Petersburg.初产妇和经产妇的早期泌乳表现与不同产科医院做法的关系:圣彼得堡的一项随机试验
Int Breastfeed J. 2007 May 8;2:9. doi: 10.1186/1746-4358-2-9.
8
Relationship between maternal parity, basal prolactin levels and neonatal breast milk intake.
Biol Neonate. 1988;53(3):144-7. doi: 10.1159/000242775.
9
Effects of oral calcium supplementation on productive and reproductive performance in Holstein cows.口服补钙对荷斯坦奶牛生产性能和繁殖性能的影响。
J Dairy Sci. 2016 Oct;99(10):8417-8430. doi: 10.3168/jds.2015-10529. Epub 2016 Aug 8.
10
Prepregnant overweight and obesity diminish the prolactin response to suckling in the first week postpartum.孕前超重和肥胖会降低产后第一周催乳素对哺乳的反应。
Pediatrics. 2004 May;113(5):e465-71. doi: 10.1542/peds.113.5.e465.

引用本文的文献

1
The Impact of Substance Use Disorder and Drug Transfer into Breast Milk: Implications for Maternal and Infant Health.物质使用障碍及药物转移至母乳中的影响:对母婴健康的启示
Pharmaceutics. 2025 May 29;17(6):719. doi: 10.3390/pharmaceutics17060719.
2
Use of Galactagogues in a Multi-Ethnic Community in Southeast Asia: A Descriptive Study.东南亚多民族社区中催乳剂的使用:一项描述性研究。
Int J Womens Health. 2022 Sep 22;14:1395-1404. doi: 10.2147/IJWH.S366288. eCollection 2022.
3
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.
用于增加非住院足月儿母亲母乳分泌量的口服催乳剂(天然疗法或药物)。
Cochrane Database Syst Rev. 2020 May 18;5(5):CD011505. doi: 10.1002/14651858.CD011505.pub2.
4
The effect of pre-operative autologous blood donation self-transfusion on hormone and postpartum convalescence in Lying-in women.术前自体血预存式输血对产妇激素及产后康复的影响
Int J Clin Exp Med. 2015 Mar 15;8(3):4515-20. eCollection 2015.
5
Pharmacological overview of galactogogues.催乳剂的药理学概述。
Vet Med Int. 2014;2014:602894. doi: 10.1155/2014/602894. Epub 2014 Aug 31.
6
Breastfeeding self-efficacy and the use of prescription medication: a pilot study.母乳喂养自我效能与处方药的使用:一项试点研究。
Obstet Gynecol Int. 2012;2012:562704. doi: 10.1155/2012/562704. Epub 2011 Dec 15.
7
A guide to the safety of CNS-active agents during breastfeeding.哺乳期使用中枢神经系统活性药物的安全性指南。
Drug Saf. 1997 Aug;17(2):127-42. doi: 10.2165/00002018-199717020-00005.
8
Lactational failure--study of risk factors in Turkish mothers.
Indian J Pediatr. 1994 May-Jun;61(3):269-76. doi: 10.1007/BF02752222.